Preoperative mean corpuscular hemoglobin affecting long‑term outcomes of hepatectomized patients with hepatocellular carcinoma

Huang,Pinzhu; Liu,Chunhong; Li,Binkui; Zheng,Yun; Zou,Ruhai; Huang,Jun; Hu,Zemin; Yuan,Yunfei

doi:10.3892/mco.2015.705

Preoperative mean corpuscular hemoglobin affecting long‑term outcomes of hepatectomized patients with hepatocellular carcinoma

Authors:
- Pinzhu Huang
- Chunhong Liu
- Binkui Li
- Yun Zheng
- Ruhai Zou
- Jun Huang
- Zemin Hu
- Yunfei Yuan
View Affiliations

Affiliations: State Key Laboratory of Oncology in South China, Department of Hepatobiliary Oncology, Sun Yat‑Sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China, Department of Hepatobiliary Surgery, Affiliated Zhongshan Hospital, Sun Yat‑Sen University, Zhongshan, Guangdong 528403, P.R. China
Published online on: December 10, 2015 https://doi.org/10.3892/mco.2015.705
Pages: 229-236

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pretreatment anemia has been reported to be associated with survival in several solid tumor types. In terms of survival, only limited data on the hemoglobin (HGB) level in hepatocellular carcinoma (HCC) have been published and no data on mean corpuscular hemoglobin (MCH) level in HCC is available. The present study sought to examine the role of HGB and MCH levels in predicting long‑term survival of patients with HCC who undergo resection. A retrospective study of 399 consecutive patients (1987‑1994) who underwent hepatic resection for HCC in Sun Yat‑Sen University Cancer Centre was performed. Serum HGB and MCH levels were examined preoperatively, and their prognostic capabilities were evaluated by Cox's proportional hazard model. Among the whole cohort, the HGB level appeared to be positively correlated with the MCH level (P<0.001). Survival analysis revealed that low levels of HGB (P=0.007) and MCH (P<0.001) were correlated with shorter overall survival (OS). Multivariate analysis revealed that MCH level was independently associated with OS (P<0.001), however, not HGB (P=0.278). In addition, 129 patients with large HCC (≥10 cm) tended to have a poorer OS (P<0.001) when compared with patients with smaller HCC. On subanalysis of patients with large HCC, MCH level also retained its stratified significance (P=0.001). Along with common clinicopathological variables, these results suggested that MCH, however, not HGB, may be useful in assessing prognosis for patients with HCC who undergo hepatectomy, particularly in identifying patients with large HCC who are most likely benefit from resection.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Tsoulfas G, Mekras A, Agorastou P and Kiskinis D: Surgical treatment for large hepatocellular carcinoma, Does size matter? ANZ J Surg. 82:510–517. 2012. View Article : Google Scholar : PubMed/NCBI
3	Poon Tung-Ping R, Fan ST and Wong J: Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 232:10–24. 2000. View Article : Google Scholar : PubMed/NCBI
4	Forner A, Llovet JM and Bruix J: Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
5	Villanueva A, Minguez B, Forner A, Reig M and Llovet JM: Hepatocellular carcinoma, Novel molecular approaches for diagnosis, prognosis and therapy. Annu Rev Med. 61:317–328. 2010. View Article : Google Scholar : PubMed/NCBI
6	Villanueva A, Hoshida Y, Toffanin S, et al: New strategies in hepatocellular carcinoma: Genomic prognostic markers. Clin Cancer Res. 16:4688–4694. 2010. View Article : Google Scholar : PubMed/NCBI
7	Ju MJ, Qiu SJ, Fan J, et al: Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation. J Gastroenterol. 44:635–642. 2009. View Article : Google Scholar : PubMed/NCBI
8	Sasaki A, Iwashita Y, Shibata K, et al: Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma. Surgery. 139:755–764. 2006. View Article : Google Scholar : PubMed/NCBI
9	Amano H, Tashiro H, Oshita A, et al: Significance of platelet count in the outcomes of hepatectomized patients with hepatocellular carcinoma exceeding the Milan criteria. J Gastrointest Surg. 15:1173–1181. 2011. View Article : Google Scholar : PubMed/NCBI
10	Mano Y, Shirabe K, Yamashita Y, et al: Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: A retrospective analysis. Ann Surg. 258:301–305. 2013. View Article : Google Scholar : PubMed/NCBI
11	Boogaerts M, Mittelman M and Vaupel P: Beyond anaemia management, Evolving role of erythropoietin therapy in neurological disorders, multiple myeloma and tumour hypoxia models. Oncology. 69((Suppl 2)): S22–S30. 2005. View Article : Google Scholar
12	Caro JJ, Salas M, Ward A and Goss G: Anemia as an independent prognostic factor for survival in patients with cancer, A systemic, quantitative review. Cancer. 91:2214–2221. 2001. View Article : Google Scholar : PubMed/NCBI
13	Holzner B, Kemmler G, Greil R, et al: The impact of hemoglobin levels on fatigue and quality of life in cancer patients. Ann Oncol. 13:965–973. 2002. View Article : Google Scholar : PubMed/NCBI
14	Van Belle: SJ andC ocquyt V: Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. Crit Rev Oncol Hematol. 47:1–11. 2003. View Article : Google Scholar : PubMed/NCBI
15	Kim JH, Lee JM, Ryu KS, et al: The prognostic impact of duration of anemia during chemotherapy in advanced epithelial ovarian cancer. Oncologist. 16:1154–1161. 2011. View Article : Google Scholar : PubMed/NCBI
16	Qiu MZ, Xu RH, Ruan DY, et al: Incidence of anemia, leukocytosis and thrombocytosis in patients with solid tumors in China. Tumour Biol. 31:633–641. 2010. View Article : Google Scholar : PubMed/NCBI
17	Wu XN, Su D, Wang L and Yu FL: Roles of the hepcidin-ferroportin axis and iron in cancer. Eur J Cancer Prev. 23:122–133. 2014. View Article : Google Scholar : PubMed/NCBI
18	Heath JL, Weiss JM, Lavau CP and Wechsler DS: Iron deprivation in cancer-potential therapeutic implications. Nutrients. 5:2836–2859. 2013. View Article : Google Scholar : PubMed/NCBI
19	Chun YH, Kim SU, Park JY, do Kim Y, Han KH, Chon CY, Kim BK, Choi GH, Kim KS, Choi JS and Ahn SH: Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. Eur J Cancer. 47:2568–2575. 2011. View Article : Google Scholar : PubMed/NCBI
20	Chen MH, Chang PM, Chen PM, et al: Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer. J Cancer Res Clin Oncol. 135:1783–1790. 2009. View Article : Google Scholar : PubMed/NCBI
21	Aapro M, Österborg A, Gascón P, Ludwig H and Beguin Y: Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. Histopathology. Ann Oncol. 23:1954–1962. 2012. View Article : Google Scholar : PubMed/NCBI
22	Intragumtornchai T, Rojnukkarin P, Swasdikul D, et al: Anemias in Thai patients with cirrhosis. Int J Hematol. 65:365–373. 1997. View Article : Google Scholar : PubMed/NCBI
23	Tseng HH, Chang JG, Hwang YH, et al: Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications. J Cancer Res Clin Oncol. 135:1413–1420. 2009. View Article : Google Scholar : PubMed/NCBI
24	Deugnier Y and Turlin B: Pathology of hepatic iron overload. Semin Liver Dis. 31:260–271. 2011. View Article : Google Scholar : PubMed/NCBI
25	Reichel O, Panzer M, Wimmer C, et al: Prognostic implications of hemoglobin levels before and after surgery as well as before and after radiochemotherapy for head and neck tumors. Eur Arch Otorhinolaryngol. 260:248–253. 2003.PubMed/NCBI
26	Cordella C, Luebbers HT, Rivelli V, Grätz KW and Kruse AL: An evaluation of the preoperative hemoglobin level as a prognostic factor for oral squamous cell carcinoma. Head Neck Oncol. 3:352011. View Article : Google Scholar : PubMed/NCBI
27	Tomita M, Shimizu T, Hara M, Ayabe T and Onitsuka T: Impact of preoperative hemoglobin level on survival of non-small cell lung cancer patients. Anticancer Res 28 (3B). 1947–1950. 2008.
28	Yovino S, Kwok Y, Krasna M, et al: An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone. Int J Radiat Oncol Biol Phys. 62:1438–1443. 2005. View Article : Google Scholar : PubMed/NCBI
29	Juncà J, Fernández-Avilés F, Oriol A, et al: The usefulness of the serum transferrin receptor in detecting iron deficiency in the anemia of chronic disorders. Haematologica. 83:676–680. 1998.PubMed/NCBI
30	Alquaiz JM, Abdulghani HM, Khawaja RA and Shaffi-Ahamed S: Accuracy of various iron parameters in the prediction of iron deficiency anemia among healthy women of child bearing age, Saudi Arabia. Iran Red Crescent Med J. 14:397–401. 2012.PubMed/NCBI
31	Iolascon A: DeF alco L and Beaumont C: Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis. Haematologica. 94:395–408. 2009. View Article : Google Scholar : PubMed/NCBI
32	Batts KP: Iron overload syndromes and the liver. Mod Pathol. 20((Suppl 1)): S31–S39. 2007. View Article : Google Scholar : PubMed/NCBI
33	Truant S, Boleslawski E, Duhamel A, et al: Tumor size of hepatocellular carcinoma in noncirrhotic liver: A controversial predictive factor for outcome after resection. Eur J Surg Oncol. 38:1189–1196. 2012. View Article : Google Scholar : PubMed/NCBI
34	Zhong JH, Ke Y, Gong WF, et al: Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg. 260:329–340. 2014. View Article : Google Scholar : PubMed/NCBI
35	Shah SA, Wei AC, Cleary SP, Yang I, McGilvray ID, Gallinger S, Grant DR and Greig PD: Prognosis and results after resection of very large (>or=10 cm) hepatocellular carcinoma. J Gastrointest Surg. 11:589–595. 2007. View Article : Google Scholar : PubMed/NCBI
36	Mok KT, Wang BW, Lo GH, et al: Multimodality management of hepatocellular carcinoma larger than 10 cm. J Am Coll Surg. 197:730–738. 2003. View Article : Google Scholar : PubMed/NCBI
37	Shrager B, Jibara GA, Tabrizian P, et al: Resection of large hepatocellular carcinoma (≥10 cm): A unique western perspective. J Surg Oncol. 107:111–117. 2013. View Article : Google Scholar : PubMed/NCBI